𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Chemotherapy for spinal cord astrocytoma

✍ Scribed by Bouffet, Eric; Amat, Didier; Devaux, Yves; Desuzinges, Claude

Publisher
John Wiley and Sons
Year
1997
Tongue
English
Weight
97 KB
Volume
29
Category
Article
ISSN
0098-1532

No coin nor oath required. For personal study only.

✦ Synopsis

Background. The optimal management of spinal cord astrocytomas remains to be defined, as aggressive surgery and radiotherapy are associated with a high risk of morbidity. The value of chemotherapy has not been assessed.

Procedure. The patient in the present report harbored an infiltrating spinal cord tumor causing paraplegia. A limited biopsy showed a grade II astrocytoma. Following biopsy, the patient received sequential chemotherapy with vincristine and carboplatin.

Results. Full neurological recovery and complete radiologically-confirmed remission were achieved after eight months of treatment. Chemotherapy was discontinued after eleven months due to carboplatin hypersensitivity. No adjuvant radiotherapy was given, and the patient remains in complete remission fourteen months after completion of treatment.

Conclusions. Chemotherapy demonstrates a promising activity and could change the standard practice if its efficacy is confirmed in larger studies. It could be used alone or combined with radiotherapy when post-operative treatment is recommended. Med. Pediatr. Oncol. 29:560-562, 1997.

πŸ“œ SIMILAR VOLUMES

Chemotherapy for spinal cord astrocytoma
Chemotherapy for spinal cord astrocytoma
✍ Foreman, Nicholas K.; Hay, Thomas C.; Handler, Michael πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 265 KB πŸ‘ 1 views
Prognostic factors in pediatric spinal c
Prognostic factors in pediatric spinal cord astrocytoma
✍ Eric Bouffet; Alain Pierre-Kahn; Jean Claude Marchal; Anne Jouvet; Chantal Kalif πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 118 KB πŸ‘ 2 views

## BACKGROUND. Factors that could optimize the management of pediatric spinal cord astrocytoma remain unclear and controversial. ## METHODS. To determine the factors that influence the prognosis of pediatric patients with spinal cord astrocytomas, a series of 73 consecutive patients at 13 Fren

Intramedullary spinal cord astrocytoma v
Intramedullary spinal cord astrocytoma versus glioblastoma. The prognostic importance of histologic grade
✍ Gene Kopelson; Rita M. Linggood πŸ“‚ Article πŸ“… 1982 πŸ› John Wiley and Sons 🌐 English βš– 334 KB πŸ‘ 2 views

Fourteen patients with intramedullary spinal cord astrocytoma (Grades I, 11) or glioblastoma (Grades 111, IV) were seen at a major referral center over a 19-year period. Although similar surgical and radiotherapeutic techniques were used for each group, the nine patients with astrocytoma had a five-

Chemotherapy for acute lymphoblastic leu
Chemotherapy for acute lymphoblastic leukemia may cause subtle changes of the spinal cord detectable by somatosensory evoked potentials
✍ VainionpÀÀ, Leena; Kovala, Tero; Tolonen, Uolevi; Lanning, Marjatta πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 76 KB πŸ‘ 2 views

Intrathecal chemotherapy has been deter-ALL after receiving intrathecal methotrexate mined to cause transient or permanent parapare-therapy during the induction and CNS therapy sis due to myelopathy in patients with leukemia phases when compared with their controls. The or other malignancies. To sys

Therapy for patients with high grade ast
Therapy for patients with high grade astrocytoma using intraarterial chemotherapy and radiation therapy
✍ Stefan Madajewicz; Naveed Chowhan; Arafat Tfayli; Clemente Roque; Allen Meek; Ra πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 202 KB πŸ‘ 1 views

## Background: High grade astrocytomas account for approximately 40% of all primary brain tumors. the median survival is approximately 8-10 months for patients with glioblastoma multiforme and 36 months for patients with anaplastic astrocytoma. the results of systemic chemotherapy in the treatment